Co-Amlessa tablets

البلد: أرمينيا

اللغة: الإنجليزية

المصدر: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

خصائص المنتج خصائص المنتج (SPC)
22-10-2020

العنصر النشط:

perindopril (perindopril tert-butylamine), amlodipine (amlodipine besilate), indapamide

متاح من:

KRKA d.d.

ATC رمز:

C09BX01

INN (الاسم الدولي):

perindopril (perindopril tert-butylamine), amlodipine (amlodipine besilate), indapamide

جرعة:

4mg+ 10mg+ 1,25mg

الشكل الصيدلاني:

tablets

الوحدات في الحزمة:

(30/3x10/) in blister

نوع الوصفة الطبية :

Prescription

الوضع إذن:

Registered

تاريخ الترخيص:

2016-07-20

خصائص المنتج

                                Summary of product characteristics
CONFIDENTIAL
Co-Amlessa tablet 2 mg/5 mg/0.625 mg, 4 mg/5 mg/1.25
mg, 4 mg/10 mg/1.25 mg, 8 mg/5 mg/2.5 mg, 8 mg/10
VOL: 1; P: 68 / 1048
1.3.1
Perindopril+Indapamide+Amlodipine
SPC, Labeling and Package Leaflet
AM
SmPCPIL153367_1
20.07.2020 – Updated: 20.07.2020
Page 1 of 27
1.
NAME OF THE MEDICINAL PRODUCT
Co-Amlessa 2 mg/5 mg/0.625 mg tablets
Co-Amlessa 4 mg/5 mg/1.25 mg tablets
Co-Amlessa 4 mg/10 mg/1.25 mg tablets
Co-Amlessa 8 mg/5 mg/2.5 mg tablets
Co-Amlessa 8 mg/10 mg/2.5 mg tablets
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Co-Amlessa 2 mg/5 mg/0.625 mg tablets
Each tablet
contains 2 mg perindopril tert-butylamine, 5 mg amlodipine (as
besilate) and 0.625 mg
indapamide.
Co-Amlessa 4 mg/5 mg/1.25 mg tablets
Each tablet
contains 4 mg perindopril tert-butylamine, 5 mg amlodipine (as
besilate) and 1.25 mg
indapamide.
Co-Amlessa 4 mg/10 mg/1.25 mg tablets
Each tablet
contains 4 mg perindopril tert-butylamine, 10 mg amlodipine (as
besilate) and 1.25 mg
indapamide.
Co-Amlessa 8 mg/5 mg/2.5 mg tablets
Each tablet contains 8 mg perindopril tert-butylamine, 5 mg amlodipine
(as besilate) and 2.5 mg
indapamide.
Co-Amlessa 8 mg/10 mg/2.5 mg tablets
Each tablet
contains 8 mg perindopril tert-butylamine, 10 mg amlodipine (as
besilate) and 2.5 mg
indapamide.
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Tablet.
Co-Amlessa 2 mg/5 mg/0.625 mg tablets: White to almost white, oval,
biconvex tablets scored on one
side. The score line is only to facilitate breaking for ease of
swallowing and not to divide into equal
doses.
Co-Amlessa 4 mg/5 mg/1.25 mg tablets: White to almost white, round,
slightly biconvex tablets with
bevel edges.
Co-Amlessa 4 mg/10 mg/1.25 mg tablets: White to almost white, oval,
biconvex tablets scored on one
side. The tablet can be divided into equal doses.
Co-Amlessa 8 mg/5 mg/2.5 mg tablets: White to almost white, round,
biconvex tablets with bevel
edges.
Co-Amlessa 8 mg/10 mg/2.5 mg tablets: White to almost white, round,
biconvex tablets s
                                
                                اقرأ الوثيقة كاملة
                                
                            

مستندات بلغات أخرى

نشرة المعلومات نشرة المعلومات الروسية 22-10-2020

تنبيهات البحث المتعلقة بهذا المنتج

عرض محفوظات المستندات